🇺🇸 FDA
Patent

US 8158754

Multiple modified derivatives of gelatin and crosslinked material thereof

granted A61KA61K47/42A61K9/06

Quick answer

US patent 8158754 (Multiple modified derivatives of gelatin and crosslinked material thereof) held by BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.
Grant date
Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K47/42, A61K9/06